Teachers Advisors LLC Has $3.39 Million Stake in HealthEquity, Inc. (NASDAQ:HQY)
Teachers Advisors LLC raised its position in HealthEquity, Inc. (NASDAQ:HQY) by 6.0% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 79,893 shares of the company’s stock after buying an additional 4,542 shares during the period. Teachers Advisors LLC’s holdings in HealthEquity were worth $3,391,000 as of its most recent filing with the SEC.
Several other large investors have also bought and sold shares of HQY. Glen Harbor Capital Management LLC raised its stake in HealthEquity by 0.4% in the first quarter. Glen Harbor Capital Management LLC now owns 43,956 shares of the company’s stock valued at $1,866,000 after buying an additional 154 shares during the period. Quantbot Technologies LP increased its position in HealthEquity by 83.4% in the first quarter. Quantbot Technologies LP now owns 6,883 shares of the company’s stock worth $292,000 after buying an additional 3,129 shares in the last quarter. Pier Capital LLC bought a new position in HealthEquity during the first quarter worth $5,708,000. Norges Bank bought a new position in HealthEquity during the fourth quarter worth $14,203,000. Finally, IronBridge Capital Management LP bought a new position in HealthEquity during the first quarter worth $2,957,000. Institutional investors own 90.26% of the company’s stock.
Shares of HealthEquity, Inc. (NASDAQ HQY) traded up 0.50% on Friday, reaching $46.37. 71,488 shares of the company’s stock traded hands. The firm’s 50-day moving average is $48.92 and its 200-day moving average is $46.14. The stock has a market cap of $2.78 billion, a price-to-earnings ratio of 87.16 and a beta of 1.73. HealthEquity, Inc. has a 52-week low of $28.39 and a 52-week high of $54.95.
HealthEquity (NASDAQ:HQY) last posted its quarterly earnings results on Tuesday, June 6th. The company reported $0.19 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.16 by $0.03. The business had revenue of $55.40 million during the quarter, compared to analyst estimates of $54.77 million. HealthEquity had a net margin of 17.04% and a return on equity of 11.61%. The company’s revenue was up 25.9% on a year-over-year basis. During the same period in the prior year, the business posted $0.15 earnings per share. Analysts anticipate that HealthEquity, Inc. will post $0.58 EPS for the current fiscal year.
HQY has been the subject of a number of research reports. Chardan Capital increased their target price on shares of HealthEquity from $53.00 to $57.00 and gave the company a “buy” rating in a research report on Wednesday, June 7th. Cantor Fitzgerald increased their target price on shares of HealthEquity from $50.00 to $55.00 and gave the company an “overweight” rating in a research report on Wednesday, June 7th. Oppenheimer Holdings, Inc. reissued an “outperform” rating and set a $61.00 target price (up from $57.00) on shares of HealthEquity in a research report on Monday, June 12th. Zacks Investment Research raised shares of HealthEquity from a “hold” rating to a “buy” rating and set a $54.00 target price for the company in a research report on Wednesday, July 12th. Finally, BidaskClub downgraded shares of HealthEquity from a “buy” rating to a “hold” rating in a research report on Monday, July 24th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and eleven have assigned a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $50.22.
In other HealthEquity news, Director Frank Medici sold 537,102 shares of the company’s stock in a transaction that occurred on Friday, July 14th. The shares were sold at an average price of $51.24, for a total value of $27,521,106.48. Following the completion of the transaction, the director now directly owns 6,381 shares in the company, valued at $326,962.44. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Stephen Neeleman sold 8,500 shares of the company’s stock in a transaction that occurred on Monday, July 17th. The stock was sold at an average price of $50.83, for a total transaction of $432,055.00. Following the completion of the transaction, the insider now owns 1,000 shares of the company’s stock, valued at $50,830. The disclosure for this sale can be found here. Over the last quarter, insiders sold 2,440,821 shares of company stock valued at $125,325,268. Company insiders own 29.00% of the company’s stock.
HealthEquity Company Profile
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY).
Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with MarketBeat.com's FREE daily email newsletter.